In2Bones Gains FDA Clearance for Quantum Total Ankle

In2Bones entered the total ankle market with FDA 510(k) clearance to market the Quantum™ Total Ankle. Initial launch will begin in mid-2020, followed by full launch in 1Q21.

Quantum features an anatomically designed talus with a dual radius of curvature to improve the patient's dorsi and plantar flexion. The system has a cruciate shaped...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

  • This field is for validation purposes and should be left unchanged.

0